MedPath

Feasibility Test of Virtual Reality Obstacle Detection for Low Vision Walking

Not Applicable
Active, not recruiting
Conditions
Homonymous Hemianopia
Tunnel Vision
Visual Field Defect Homonymous Bilateral
Hemianopsia
Visual Field Constriction Bilateral
Visual Field Defect, Peripheral
Interventions
Other: Field expansion view
Registration Number
NCT05141604
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Brief Summary

The investigators are developing a new test of pedestrian hazard detection in virtual reality (VR) head-mounted display (HMD) headset, which shows virtual oncoming pedestrians in 3D while subjects are walking in real-world environment, for evaluation of visual field expansion to improve mobility in people with visual field loss.

Detailed Description

The investigators will develop a new pedestrian hazard detection test and conduct a single arm interventional clinical trial to evaluate simulated low vision assistive devices in a sample of field loss subjects. Pedestrian detection performance with and without field expansion information will be tested and compared. The study will include 1 to 4 visits (each 2 to 4 hours) depending on the number of trials and experimental conditions (e.g., with and without simulated assistive devices) the subject is comfortable completing. The time between visits may vary depending on scheduling constraints and availability. During each visit, the subject will complete a series of simulated collision avoidance trials in VR requiring the detection and natural avoidance of a colliding pedestrian (alongside non-colliding pedestrians) while physically walking through an empty corridor. The study will be considered minimal-risk since there will be no physical obstacles that present actual collision risks.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
15
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Field expansion viewField expansion viewVarious configurations of field expansion views will be additionally displayed on HMD
Primary Outcome Measures
NameTimeMethod
Response timeThrough study completion, an average of four months

During the pedestrian detection task, average response time to the colliding pedestrian with and without prisms

Secondary Outcome Measures
NameTimeMethod
Head movement rangeThrough study completion, an average of four months

During the pedestrian detection task, lateral and vertical head movement range to check the head scanning range

Walking speedThrough study completion, an average of four months

During the pedestrian detection task, the physical walking speed of the subject

Error rateThrough study completion, an average of four months

Proportion of false alarms and missed targets to total targets

Pedestrian detection rateThrough study completion, an average of four months

Proportion of simulated pedestrians detected (in HMD walking)

Trial Locations

Locations (1)

Schepens Eye Research Institute

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath